The collaboration will focus on enhancing surgeon capabilities, developing structured training pathways, and promoting the adoption of robotic-assisted surgery in both routine and complex procedures
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes
The state-of-the-art facility is expected to be commissioned over the next three years
Phase 3 program for NDV-01 in non-muscle invasive bladder cancer expected to begin in the first half of 2026
Ultra-high purity surfactant for biologics and parenteral drug formulations
The complex four-hour surgery was performed by a multidisciplinary team of doctors
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
Subscribe To Our Newsletter & Stay Updated
